Loxo Oncology, Inc. Operating Cash Flow
Loxo Oncology, Inc. reported Operating Cash Flow of $13.42 million for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2018-11-08
- Loxo Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2018-09-30 was -$61.43M.
- Loxo Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2018-06-30 was -$34.92M.
- Loxo Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2018-03-31 was $109.77M.
- Loxo Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2017-12-31 was $220.88M.
- Loxo Oncology, Inc. net cash provided by (used in) operating activities for fiscal 2017 was $107.76M.
- Loxo Oncology, Inc. net cash provided by (used in) operating activities for fiscal 2016 was -$51.32M.
- Loxo Oncology, Inc. net cash provided by (used in) operating activities for fiscal 2015 was -$30.18M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|
| 2018-09-30 | -$61.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$96.35M derived: sum of 2 quarters · filed 2018-11-08 | $13.42M 10-Q · filed 2018-11-08 | $234.30M derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2018-06-30 | -$34.92M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $74.85M 10-Q · filed 2018-08-09 | $295.73M derived: sum of 3 quarters · filed 2018-08-09 | $232.84M derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2018-03-31 | $109.77M 10-Q · filed 2018-05-08 | $330.65M derived: sum of 2 quarters · filed 2018-05-08 | $267.76M derived: sum of 3 quarters · filed 2018-11-08 | $244.21M derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2017-12-31 | $220.88M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $157.99M derived: sum of 2 quarters · filed 2018-11-08 | $134.44M derived: sum of 3 quarters · filed 2018-11-08 | $107.76M 10-K · filed 2018-03-01 | ||
| 2017-09-30 | -$62.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$86.44M derived: sum of 2 quarters · filed 2018-11-08 | -$113.12M 10-Q · filed 2018-11-08 | -$113.43M 10-Q · filed 2017-11-02 | -$127.70M derived: sum of 4 quarters · filed 2018-11-08 | |
| 2017-06-30 | -$23.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$50.23M 10-Q · filed 2018-08-09 | -$50.54M 10-Q · filed 2017-08-08 | -$64.81M derived: sum of 3 quarters · filed 2018-08-09 | -$80.16M derived: sum of 4 quarters · filed 2018-08-09 | |
| 2017-03-31 | -$26.68M 10-Q · filed 2018-05-08 | -$41.26M derived: sum of 2 quarters · filed 2018-05-08 | -$56.61M derived: sum of 3 quarters · filed 2018-05-08 | |||
| 2016-12-31 | -$14.58M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$29.94M derived: sum of 2 quarters · filed 2018-03-01 | -$51.32M 10-K · filed 2018-03-01 | |||
| 2016-09-30 | -$15.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | -$36.74M 10-Q · filed 2017-11-02 | ||||
| 2016-06-30 | -$21.38M 10-Q · filed 2017-08-08 | |||||
| 2015-12-31 | -$30.18M 10-K · filed 2018-03-01 |